Not applicableUnknownNCT01957241What this trial is testingPLA for HCC and Esophageal ca SerumWho this might be right forHepatocellular CarcinomaEsophageal Cancer National Taiwan University Hospital 164
Large-scale testing (Phase 3)Study completedNCT03802591What this trial is testingCS1001 in Subjects With Gastric Adenocarcinoma or Gastro-Esophageal Junction AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma CStone Pharmaceuticals 479
Testing effectiveness (Phase 2)Ended earlyNCT03122548What this trial is testingSafety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal CancersWho this might be right forGastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma Aduro Biotech, Inc. 5
Early research (Phase 1)UnknownNCT03734926What this trial is testingZSP1241 in Participants With Advanced Solid TumorsWho this might be right forHepatocellular CarcinomaCholangiocarcinomaGastric Cancer+2 more Guangdong Zhongsheng Pharmaceutical Co., Ltd. 90
Not applicableUnknownNCT04818476What this trial is testingOutcomes of Endoscopically Resected High-risk Mucosal and Low- and High-risk Submucosal Adenocarcinoma Arising in Barrett's EsophagusWho this might be right forBarrett EsophagusAdenocarcinoma EsophagusSubmucosal Esophageal Adenocarcinoma+1 more Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,000
Early research (Phase 1)Study completedNCT03538028What this trial is testingA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesWho this might be right forCervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more Incyte Biosciences International Sàrl 22
Not applicableNot Yet RecruitingNCT07260734What this trial is testingAUGMENTED RESPONSE OF VOLATILE BIOMARKERS IN THE ASSESSMENT OF OESOPHAGOGASTRIC CANCER (AROMA2)Who this might be right forOESOPHAGO-GASTRIC CARCINOMAOesophageal AdenocarcinomaGastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma+5 more Imperial College London 6,000
Testing effectiveness (Phase 2)Study completedNCT00757172What this trial is testingPanitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal JunctionWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer Alliance for Clinical Trials in Oncology 70
Testing effectiveness (Phase 2)Looking for participantsNCT05651594What this trial is testingPropranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction AdenocarcinomaWho this might be right forClinical Stage II Esophageal Adenocarcinoma AJCC v8Clinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+8 more Roswell Park Cancer Institute
Early research (Phase 1)Ended earlyNCT00368329What this trial is testingPhase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal CancerWho this might be right forEsophageal NeoplasmsCarcinoma, Squamous CellAdenocarcinoma+1 more Stanford University 4
Testing effectiveness (Phase 2)Study completedNCT01855854What this trial is testingSecond-line Treatment With Icotinib in Esophageal Carcinoma Patients With EGFR Overexpression (IHC 3+) or Positive FISHWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionEsophageal Carcinoma Betta Pharmaceuticals Co., Ltd. 54
Early research (Phase 1)Study completedNCT02138929What this trial is testingLDE225 + Everolimus in Advanced Gastroesophageal AdenocarcinomaWho this might be right forEsophageal Cancer M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT01130337What this trial is testingCapecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric CancerWho this might be right forGastric Cancer Hoffmann-La Roche 36
Testing effectiveness (Phase 2)Study completedNCT00215644What this trial is testingMatuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric CancerWho this might be right forEsophageal CancerGastric Cancer Merck KGaA, Darmstadt, Germany 72
Early research (Phase 1)Looking for participantsNCT06266299What this trial is testingKK2269 in Adult Participants With Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorGastric Adenocarcinoma+3 more Kyowa Kirin Co., Ltd. 101
Testing effectiveness (Phase 2)Study completedNCT01231399What this trial is testingEverolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal CancerWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+6 more City of Hope Medical Center 6
Testing effectiveness (Phase 2)Study completedNCT00470184What this trial is testingOxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal CancerWho this might be right forEsophageal Cancer Roswell Park Cancer Institute 41
Early research (Phase 1)Study completedNCT01630798What this trial is testingA In-Vivo Esophageal Protocol for Detection of Neoplasia in the Digestive TractWho this might be right forBarrett's Esophagus University of Michigan 60
Large-scale testing (Phase 3)Study completedNCT01404156What this trial is testingPreoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ AdenocarcinomaWho this might be right forEsophageal CancerAdenocarcinoma, EsophagealAdenocarcinoma, Gastroesophageal Junction Dr. Gordon Buduhan 29
Testing effectiveness (Phase 2)Study completedNCT00017212What this trial is testingDX-8951f in Treating Patients With Metastatic Stomach CancerWho this might be right forEsophageal CancerGastric Cancer Daiichi Sankyo